Correlation Between OmniAb and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both OmniAb and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OmniAb and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OmniAb Inc and Seres Therapeutics, you can compare the effects of market volatilities on OmniAb and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OmniAb with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of OmniAb and Seres Therapeutics.
Diversification Opportunities for OmniAb and Seres Therapeutics
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between OmniAb and Seres is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding OmniAb Inc and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and OmniAb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OmniAb Inc are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of OmniAb i.e., OmniAb and Seres Therapeutics go up and down completely randomly.
Pair Corralation between OmniAb and Seres Therapeutics
Assuming the 90 days horizon OmniAb Inc is expected to generate 1.41 times more return on investment than Seres Therapeutics. However, OmniAb is 1.41 times more volatile than Seres Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.14 per unit of risk. If you would invest 30.00 in OmniAb Inc on September 1, 2024 and sell it today you would earn a total of 4.00 from holding OmniAb Inc or generate 13.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 71.43% |
| Values | Daily Returns |
OmniAb Inc vs. Seres Therapeutics
Performance |
| Timeline |
| OmniAb Inc |
| Seres Therapeutics |
OmniAb and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OmniAb and Seres Therapeutics
The main advantage of trading using opposite OmniAb and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OmniAb position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| OmniAb vs. Tff Pharmaceuticals | OmniAb vs. Eliem Therapeutics | OmniAb vs. Inhibrx | OmniAb vs. Enliven Therapeutics |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |